Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elias Jabbour Susan O'Brien William G Wierda Gautam Borthakur Constantine S. Tam Jorge Eduardo Cortes Jan A Burger Hagop Kantarjian |
| Publication date | June 30, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |